2 Healthcare Stocks to Buy Before They Get Bought Out | The Motley Fool
Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.

Source: The Motley Fool
Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.